SPRO icon

Spero Therapeutics
SPRO

Overview Fund Trends Analyst Outlook Journalist POV

79 hedge funds and large institutions have $15.5M invested in Spero Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

54% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 35

91% less capital invested

Capital invested by funds: $180M → $15.5M (-$164M)

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$36K
Puts
$34K
Net Calls
Net Calls Change

Top Buyers

1
+$1.11M
2
+$615K
3
+$467K
4
Two Sigma Investments
Two Sigma Investments
New York
+$266K
5
OMC
Oasis Management Company
Cayman Islands
+$213K

Top Sellers

1
-$5.1M
2
-$3.24M
3
-$1.71M
4
GIM
Granahan Investment Management
Massachusetts
-$986K
5
BlackRock
BlackRock
New York
-$819K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
90
–
91
–
92
–
93
–
94
–
95
–
96
–
97
–
98
–
99
–
100
–
1 2 3
4
5